Product
Inhaled Nitric Oxide
Aliases
inhaled nitric oxide, inhaled Nitric Oxide, inhaled NO, iNO
12 clinical trials
9 indications
Indication
Chronic Obstructive Pulmonary DiseaseIndication
Pulmonary HypertensionIndication
Pulmonary Arterial HypertensionIndication
Idiopathic Pulmonary FibrosisIndication
Traumatic Brain InjuryIndication
Healthy SubjectsIndication
Congenital Heart DefectIndication
Congenital Diaphragmatic HerniaIndication
Bronchopulmonary DysplasiaClinical trial
Exploratory Study to Assess the Effect of Pulsed Inhaled Nitric Oxide on Functional Respiratory Imaging Parameters in Subjects With WHO Group 3 Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (COPD) on Long Term Oxygen Therapy (LTOT).Status: Terminated, Estimated PCD: 2017-08-21
Clinical trial
An Open-Label Long-Term Safety Study of Inhaled Nitric Oxide (iNO) for PAH for Subjects in the PULSE-PAH-006 and PULSE-PAH-004 Studies Who Continue to Need iNO TherapyStatus: , Estimated PCD: 2023-04-01
Clinical trial
An Exploratory, 3-Part, Clinical Study to Assess the Effect of Pulsed, Inhaled Nitric Oxide (iNO) on Functional Pulmonary Imaging Parameters in Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) on Long-Term Oxygen Therapy (LTOT) (Part 1) and in Subjects With WHO Group 3 PH Associated With Idiopathic Pulmonary Fibrosis (IPF) on LTOT (Part 2 and Part 3)Status: Completed, Estimated PCD: 2017-06-01
Clinical trial
A Phase 3, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Efficacy, Safety, and Tolerability of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Symptomatic Subjects With PAH (Part 1 and Part 2)Status: Terminated, Estimated PCD: 2018-08-01
Clinical trial
A Phase 2, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Safety, Tolerability and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo as Add-On Therapy in Symptomatic Subjects With Pulmonary Arterial Hypertension (PAH)Status: Completed, Estimated PCD: 2014-10-01
Clinical trial
Respiratory Mechanics Following Brain Injury: The Role of Inhaled Nitric OxideStatus: Completed, Estimated PCD: 2023-12-28
Clinical trial
Kinetics of Methemoglobin Concentration in Healthy Subjects Exposed to High Dose Inhaled Nitric OxideStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPDStatus: Not yet recruiting, Estimated PCD: 2025-12-01
Clinical trial
Inhaled Nitric Oxide for Microvascular Dysfunction in Traumatic Brain InjuryStatus: Not yet recruiting, Estimated PCD: 2027-08-31
Clinical trial
The Effects of Inhaled Nitric Oxide on Patient Morbidity and Length of Hospital Stay Following Fontan OperationStatus: Completed, Estimated PCD: 2011-12-01
Clinical trial
Inhaled Nitric Oxide (iNO) for Congenital Diaphragmatic Hernia (CDH) - The "NoNO Trial" - a Multi-center, De-implementation, Stepped-wedge, Cluster-randomized Trial Within an Established CollaborativeStatus: Not yet recruiting, Estimated PCD: 2029-12-31
Clinical trial
Treatment of Delayed Pulmonary Transition in Extremely Preterm Infants & Bronchopulmonary DysplasiaStatus: Recruiting, Estimated PCD: 2024-12-01